Tumor–Immune Cell Interactions in Cancer Progression

The tumor microenvironment is a complex ecosystem where immune cell components play a pivotal role in cancer progression. Aberrant immune responses within the tumor microenvironment are critical in tumor initiation, progression, metastasis, and prognosis, highlighting the urgent need to unravel tumor-immune interactions for improved therapies. This commentary reviews recent advancements in understanding tumor-immune interactions, focusing on both intrinsic factors, like cancer genetics and epigenetics, and extrinsic factors, such as metabolic reprogramming. We also examine key mechanisms of tumor-immune cross-talk, including exosome-mediated communication, liquid-liquid phase separation, and circulating tumor cells. Furthermore, we propose future research directions to improve strategies for combating cancer metastasis and enhancing therapeutic efficacy.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2025-08-15
DOI
https://doi.org/10.1158/0008-5472.can-24-2760
Citations
2
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
1.59

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tumor–Immune Cell Interactions in Cancer Progression

Long Zhang, Xiaoxue Zhou, Feng Xie
2 citations
Cancer Research
Immune cells in cancer
1.59
article

Tumor–Immune Cell Interactions in Cancer Progression

Long Zhang, Xiaoxue Zhou, Feng Xie
article en
2 citations

Abstract

The tumor microenvironment is a complex ecosystem where immune cell components play a pivotal role in cancer progression. Aberrant immune responses within the tumor microenvironment are critical in tumor initiation, progression, metastasis, and prognosis, highlighting the urgent need to unravel tumor-immune interactions for improved therapies. This commentary reviews recent advancements in understanding tumor-immune interactions, focusing on both intrinsic factors, like cancer genetics and epigenetics, and extrinsic factors, such as metabolic reprogramming. We also examine key mechanisms of tumor-immune cross-talk, including exosome-mediated communication, liquid-liquid phase separation, and circulating tumor cells. Furthermore, we propose future research directions to improve strategies for combating cancer metastasis and enhancing therapeutic efficacy.

Cancer ResearchVol. 85(16)
Nanchang University (CN), Hangzhou Normal University (CN), Chengdu Medical College (CN), Soochow University (CN), First Affiliated Hospital of Jiangxi Medical College (CN), First Affiliated Hospital of Soochow University (CN), Second Affiliated Hospital of Zhejiang University (CN), Chemical Synthesis Lab (SG), First Affiliated Hospital of Nanchang University (CN), Hangzhou City University, Zhejiang University (CN)
National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China
Openalex Percentile: Top 15%
Immune cells in cancer
1.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tumor–Immune Cell Interactions in Cancer Progression — Long Zhang, Xiaoxue Zhou, et al. · Cancer Research (2025) | TGRS Research Map | TGRS